Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Stem cell therapy shows promise for hair loss treatment, but more research is needed to confirm its effectiveness.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Activating Wnt in skin cells controls the number of hair follicles by directing cell movement and fate.

m-Aminophenol in hair dye can cause skin cell toxicity and stress responses.

Stem cell treatments show promise for hair loss but need more research.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Green tea compound EGCG helps mink hair follicles grow by affecting certain cell growth pathways.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Itraconazole may cause low platelet and white blood cell counts.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Different materials affect the growth of brain cells and fibroblasts, with matrigel being best for brain cell growth.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Human skin can make serotonin and melatonin.